Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered

Phase 1 Completed 14 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of multiple doses of verapamil on the plasma concentration of a single dose of SAM-531 in healthy young adult subjects and to assess the safety and tolerability of co-administration of SAM-531 and verapamil.

Timeline

Start: 2008-10
Primary completion: 2008-12
Completion: 2008-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CERLAPIRDINE	Small molecule	—	Oral

Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered

Summary

Timeline

Drugs

Indications